Rybelsus 3 mg
  1. Home
  2. Rybelsus
  3. Rybelsus 3 mg

Rybelsus 3 mg

Rybelsus 3 mg is a prescription oral GLP-1 receptor agonist containing semaglutide for improving glycemic control in adults with type 2 diabetes when used alongside diet and exercise. It provides convenient once-daily oral administration without the need for injections. The 3 mg strength is commonly used as the initial treatment dose according to the prescribed therapy plan.

BUY NOW

Category

Rybelsus 3 mg contains semaglutide, a GLP-1 receptor agonist that helps improve blood glucose control by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The oral formulation offers an effective non-injectable option for patients requiring GLP-1 therapy, with the 3 mg strength typically serving as the starting dose before dose escalation when appropriate. Manufactured under stringent pharmaceutical quality standards, the tablets are supplied in blister packs for convenient daily administration. Rybelsus should be taken only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Rybelsus 3 mg
Active Ingredient Semaglutide
Strength 3 mg
Dosage Form Oral Tablets
Route of Administration Oral
Storage Store below 30°C in a dry place

Product Also Known As

Rybelsus 3 mg, Semaglutide 3 mg, Rybelsus Oral Tablets, Oral Semaglutide, GLP-1 Diabetes Tablets, Once-Daily Semaglutide, Semaglutide Oral Medication